Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLoans and Notes ReceivablesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Receivables - Other (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Receivables - Other over the past 15 years, most recently at $7.0 million for Q2 2025.

  • Quarterly results put Receivables - Other at $7.0 million for Q2 2025, up 71.52% from a year ago — trailing twelve months through May 2025 was $7.0 million (up 71.52% YoY), and the annual figure for FY2025 was $7.0 million, up 71.52%.
  • Receivables - Other for Q2 2025 was $7.0 million at Lifecore Biomedical, Inc. \De\, up from $6.1 million in the prior quarter.
  • Over the last five years, Receivables - Other for LFCR hit a ceiling of $13.9 million in Q1 2022 and a floor of $100000.0 in Q2 2021.
  • Median Receivables - Other over the past 5 years was $5.7 million (2024), compared with a mean of $6.7 million.
  • Peak annual rise in Receivables - Other hit 3400.0% in 2021, while the deepest fall reached 80.0% in 2021.
  • Lifecore Biomedical, Inc. \De\'s Receivables - Other stood at $12.6 million in 2021, then tumbled by 33.33% to $8.4 million in 2022, then tumbled by 65.48% to $2.9 million in 2023, then surged by 96.48% to $5.7 million in 2024, then increased by 22.48% to $7.0 million in 2025.
  • The last three reported values for Receivables - Other were $7.0 million (Q2 2025), $6.1 million (Q1 2025), and $5.7 million (Q4 2024) per Business Quant data.